Haitian Creole
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
14 rezilta yo
Indolin-2-one derivatives
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
The present invention is concerned with indolin-2-one derivatives of general formula
##STR00002## wherein A is phenyl or a six membered heteroaryl group, containing one or two N atoms, selected from
##STR00003## or the amine group --NR.sup.1R.sup.2 may form together with two neighboring carbon atoms
Indolin-2-one derivatives
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
The present invention is concerned with indolin-2-one derivatives of general formula
##STR00002## wherein A is phenyl or a five or six membered heteroaryl group, containing one or two N atoms, selected from
##STR00003## or the amide group --C(O)--NR.sup.1R.sup.2 may form together with two
Indolin-2-one derivatives
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
The present invention is concerned with indolin-2-one derivatives of general formula
##STR00004## wherein A is phenyl or a six membered heteroaryl group, containing one or two N atoms, selected from
##STR00005## or the oxygen atom may form together with two neighboring carbon atoms from the group A
Indolin-2-one derivatives
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
The present invention is concerned with indolin-2-one derivatives of general formula
##STR00004## wherein A is phenyl or a six membered heteroaryl group, containing one or two N atoms, selected from
##STR00005## R.sup.1 is S(O).sub.2lower alkyl, S(O).sub.2NR.sup.4R.sup.5, S(O).sub.2cycloalkyl,
Compositions and methods for treating intestinal hyperpermeability
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
TECHNICAL FIELD
The present inventions relate generally to compositions, kits, and methods for the treatment of intestinal hyperpermeability.
BACKGROUND
The intestinal epithelium separates luminal contents from the interstitium. This function is primarily determined by the integrity of the
Composition and methods for treating intestinal hyperpermeability
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
TECHNICAL FIELD
The present inventions relate generally to compositions, kits, and methods for the treatment of intestinal hyperpermeability.
BACKGROUND
The intestinal epithelium separates luminal contents from the interstitium. This function is primarily determined by the integrity of the
Compositions and methods for treating intestinal hyperpermeability
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
TECHNICAL FIELD
The present inventions relate generally to compositions, kits, and methods for the treatment of intestinal hyperpermeability.
BACKGROUND
The intestinal epithelium separates luminal contents from the interstitium. This function is primarily determined by the integrity of the
Compositions and methods for treating intestinal hyperpermeability
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
TECHNICAL FIELD
The present inventions relate generally to compositions, kits, and methods for the treatment of intestinal hyperpermeability.
BACKGROUND
The intestinal epithelium separates luminal contents from the interstitium. This function is primarily determined by the integrity of the
Compositions and methods for treating intestinal hyperpermeability
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
TECHNICAL FIELD
The present inventions relate generally to compositions, kits, and methods for the treatment of intestinal hyperpermeability.
BACKGROUND
The intestinal epithelium separates luminal contents from the interstitium. This function is primarily determined by the integrity of the
Compositions and methods for treating intestinal hyperpermeability
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
TECHNICAL FIELD
The present inventions relate generally to compositions, kits, and methods for the treatment of intestinal hyperpermeability.
BACKGROUND
The intestinal epithelium separates luminal contents from the interstitium. This function is primarily determined by the integrity of the
Treatment and prevention of Th1 and `autoimmune` diseases effected with antibiotics and/or angiotensin inhibition
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
BACKGROUND OF INVENTION
It is currently believed that the diseases known as "autoimmune" diseases are caused by the body's immune system attacking the body itself. But I have discovered that these so-called "autoimmune" diseases are actually caused by stealthy intra-cellular bacteria. I have
Probiotic Bifidobacterium adolescentis strains
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
FIELD OF THE INVENTION
The present invention relates to novel isolated strains of Bifidobacterium adolescentis which are capable of i) increasing the trans-epithelial electrical resistance (TER) of a Caco-2 cell monolayer after 10 h treatment to more than 120% of TER at treatment start, ii) inducing
Subcutaneously administrable composition containing anti-IL-6 antibody
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
BACKGROUND OF THE INVENTION
Field of the Invention
This invention is an extension of Applicants' prior invention disclosed in the above-referenced patent applications relating to novel anti-IL-6 antibodies, novel therapies and therapeutic protocols utilizing anti-IL-6 antibodies, and pharmaceutical
Method of treating allergic asthma with antibodies to IL-6
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
The sequence listing in the file named "56256o2006.txt" having a size of 332,224 bytes that was created Sep. 26, 2017 is hereby incorporated by reference in its entirety.
BACKGROUND OF THE INVENTION
Field of the Invention
This invention is an extension of Applicants' prior invention disclosed in the
Baz done ki pi konplè remèd fèy medsin te apiye nan syans
- Travay nan 55 lang
- Geri èrbal te apiye nan syans
- Remèd fèy rekonesans pa imaj
- Kat entèaktif GPS - tag zèb sou kote (vini byento)
- Li piblikasyon syantifik ki gen rapò ak rechèch ou an
- Search remèd fèy medsin pa efè yo
- Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive
Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye
